> Vietnamese researchers have moved an H5N1 vaccine into Phase III studies, after positive results from Phase I and II trials. Blog post
> Protein Sciences has granted Merck ($MRK) a non-exclusive license to its expresSF+ serum-free insect cell line for vaccine research. Press release
> A University of Alberta researcher has discovered a potential hepatitis C vaccine; there is currently no vaccine available. Press release
> French biopharma company Genticel has completed recruitment of a Phase Ib trial of ProCervix, its therapeutic HPV vaccine designed for women already infected with the virus. Press release
> Increased use of pneumococcal vaccines in children seems to have cut levels of invasive pneumococcal disease in people with HIV. Abstract
> The International AIDS Vaccine Initiative (IAVI) has awarded $875,000 in grants to two researchers identified through NineSigma's Open Innovation process. Press release
> Novartis Vaccines and Diagnostics has withdrawn its application to the European Medicines Agency for a pediatric marketing authorization for Fluad Paediatric (influenza vaccine). Press release
And Finally… Chagas' disease vaccine for pets could prevent spread of the disease to humans. Press release